229 related articles for article (PubMed ID: 32758242)
1. Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
Lobo J; Gillis AJM; van den Berg A; Looijenga LHJ
BMC Cancer; 2020 Aug; 20(1):728. PubMed ID: 32758242
[TBL] [Abstract][Full Text] [Related]
2. Interobserver Agreement in Vascular Invasion Scoring and the Added Value of Immunohistochemistry for Vascular Markers to Predict Disease Relapse in Stage I Testicular Nonseminomas.
Lobo J; Stoop H; Gillis AJM; Looijenga LHJ; Oosterhuis W
Am J Surg Pathol; 2019 Dec; 43(12):1711-1719. PubMed ID: 31490238
[TBL] [Abstract][Full Text] [Related]
3. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
[TBL] [Abstract][Full Text] [Related]
4. Defining a New Prognostic Index for Stage I Nonseminomatous Germ Cell Tumors Using CXCL12 Expression and Proportion of Embryonal Carcinoma.
Gilbert DC; Al-Saadi R; Thway K; Chandler I; Berney D; Gabe R; Stenning SP; Sweet J; Huddart R; Shipley JM
Clin Cancer Res; 2016 Mar; 22(5):1265-73. PubMed ID: 26453693
[TBL] [Abstract][Full Text] [Related]
5. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study investigating the detection of lymphovascular invasion in germ cell tumors of the testis with double staining for OCT4/CD34.
Ricci C; Franceschini T; Giunchi F; Borsato M; Mollica V; Massari F; Fiorentino M
Pathol Res Pract; 2021 Nov; 227():153637. PubMed ID: 34619577
[TBL] [Abstract][Full Text] [Related]
7. Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance.
Bobrowski A; Anson-Cartwright L; Kuhathaas K; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Hamilton RJ
J Urol; 2022 Dec; 208(6):1250-1258. PubMed ID: 35997696
[TBL] [Abstract][Full Text] [Related]
8. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents.
Gilbert DC; Chandler I; McIntyre A; Goddard NC; Gabe R; Huddart RA; Shipley J
J Pathol; 2009 Jan; 217(1):94-102. PubMed ID: 18839394
[TBL] [Abstract][Full Text] [Related]
10. CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors.
Fankhauser CD; Roth L; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Moch H; Bode PK; Beyer J; Hermanns T
BMC Cancer; 2019 Aug; 19(1):802. PubMed ID: 31412792
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3).
Seidel C; Daugaard G; Nestler T; Tryakin A; Fedyanin M; Fankhauser C; Hermanns T; Aparicio J; Heinzelbecker J; Paffenholz P; Heidenreich A; De Giorgi U; Cathomas R; Lorch A; Fingerhut A; Gayer F; Bremmer F; Giannatempo P; Necchi A; Aurilio G; Casadei C; Tran B; Dieckmann KP; Brito M; Ruf C; Oing C; Bokemeyer C
Eur J Cancer; 2020 Jun; 132():127-135. PubMed ID: 32361383
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
[TBL] [Abstract][Full Text] [Related]
13. Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.
Yuasa T; Inoshita N; Tanaka H; Urakami S; Yamamoto S; Fujii Y; Masuda H; Fukui I; Ishikawa Y; Yonese J
Int J Clin Oncol; 2015 Dec; 20(6):1198-202. PubMed ID: 25893862
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with stage II and III nonseminomatous germ cell tumors: results of a single center.
Ataergin S; Ozet A; Arpaci F; Kilic S; Beyzadeoglu M; Komurcu S
Indian J Cancer; 2007; 44(1):6-11. PubMed ID: 17401218
[TBL] [Abstract][Full Text] [Related]
15. Protein expression of the transcription factors DMRT1, TCLF5, and OCT4 in selected germ cell neoplasms of the testis.
Roth LM; Michal M; Michal M; Cheng L
Hum Pathol; 2018 Dec; 82():68-75. PubMed ID: 30067948
[TBL] [Abstract][Full Text] [Related]
16. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
Bhatti AB; Ahmed I; Ghauri RK; Saeed Q; Mir K
Asian Pac J Cancer Prev; 2014; 15(1):277-80. PubMed ID: 24528039
[TBL] [Abstract][Full Text] [Related]
18. Late Relapses in Stage I Testicular Cancer Patients on Surveillance.
Mortensen MS; Lauritsen J; Kier MG; Bandak M; Appelt AL; Agerbæk M; Holm NV; Kempel MM; von der Maase H; Daugaard G
Eur Urol; 2016 Aug; 70(2):365-71. PubMed ID: 26996661
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
[TBL] [Abstract][Full Text] [Related]
20. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]